Study Name:
Apixaban for the treatment of venous thromboembolism in patients with cancer: a prospective randomized open blinded-endpoint (CARAVAGGIO study)

Phase:
Phase 3b Trial

EudraCT Number:
2016-003093-40

National Investigator Coordinator:
Dr. Joaquim Abreu de Sousa (IPO Porto)

Participating countries:
United Kingdom, Belgique, France, Italy, The Netherlands, Germany, Polone, Israel, Spain, Portugal

Sites in Portugal:
IPO Porto
IPO Lisboa
Centro Hospitalar Lisboa Norte - Hospital de Santa Maria
Centro Hospital Trás os Montes e Alto Douro

Sponsor:
Foudazione FADOI, Milan, Italy

Status:
Authorities Approval